Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
Acumen Pharmaceuticals (NASDAQ: ABOS) will host a virtual Investor Day on Wednesday, September 16, 2026 at 10:00 a.m. ET, with registration required in advance and a webcast archived for at least one year. Acumen is a clinical-stage biopharmaceutical company developing therapeutics targeting toxic soluble amyloid beta oligomers for Alzheimer's disease; its lead candidate is sabirnetug (ACU193), currently in the Phase 2 ALTITUDE-AD trial in early symptomatic patients.
Key figures
- Event date
- Wednesday, September 16, 2026
- Event name
- Virtual Investor Day
- Event time
- 10:00 a.m. ET
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.